-The New Indian Express These scheduled medicines constitute about 18 per cent of the total domestic pharma retail market, valued around Rs 1.5 trillion. NEW DELHI: Prices of over 800 drugs under the National List of Essential Medicines (NLEM), including paracetamol, common antibiotics like azithromycin, doxycycline and medications for hypertension, diabetes and COVID-19 will increase by 10.7 per cent starting Friday. Activists slammed the move saying that it would hit the pockets of...
More »SEARCH RESULT
Total Matching Records found : 8
Despite no cap 'indication', govt put knee implant under price limit -Deepak Patel
-The Indian Express The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings. New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister’s Office (PMO) is documented as having “indicated” to representatives of foreign medical device companies in a meeting that the Indian government has no plans to...
More »Transfer of NPPA head who capped stent, implant prices sparks protests
-The Times of India The transfer of the chairman of the National Pharmceutical Pricing Authority, Bhupendra Singh, who had capped the price of stents and knee implants and exposed the huge margins being charged by corporate hospitals has evoked howls of protest from public health activists. RSS-affiliate Swadeshi Jagran Manch too has taken exception to the move, tweeting sarcastically about the “reward” given to a bureaucrat for doing a good job. The All...
More »Pharma price controls hurt consumers -Subir Roy
-The Hindu Business Line Public procurement at a negotiated price is a better option. Price curbs deter producers and don’t check pharmacy margins The Government’s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive? First came the move to extend the scope...
More »Doctor call on stent prices
-The Telegraph New Delhi: A group of Indian doctors has urged the Narendra Modi government to resist any US government or industry pressure to reverse its decisions earlier this year to impose price caps on coronary stents and knee implants. The Association of Doctors for Ethical Practices (ADEH) said on Wednesday that it is hoping the Indian government will "remain firm" on its decision to cap the prices of the devices because...
More »
